All Stories

ImmunoPrecise teases $10M ADC, bispecific collab with major biotech

ImmunoPrecise Antibodies has secured a collaboration with an undisclosed “leading biotech” to discover new antibody-drug conjugates (ADCs) and bispecific antibodies to treat cancer.

Mar 13, 2025 - 23:23
 0
ImmunoPrecise teases $10M ADC, bispecific collab with major biotech
ImmunoPrecise Antibodies has secured a collaboration with an undisclosed “leading biotech” to discover new antibody-drug conjugates (ADCs) and bispecific antibodies to treat cancer.
Read More

Tags:

Previous Article

Sotio takes up option on ADCs, while Boehringer inks GPCR discovery pact

Next Article

Eye surgery specialist BVI Medical claims $1B capital raise through owner TPG

Related Posts

Allogene’s phase 1 lymphoma data show CAR-T could ‘leapfrog’ competition: analysts

Allogene’s phase 1 lymphoma data show CAR-T could ‘leap...

Feb 14, 2025  0

Mission changes, shuttering lab to focus on clinical assets

Mission changes, shuttering lab to focus on clinical as...

Feb 28, 2025  0

FDA works to reverse layoffs, rehire lost staff: reports

FDA works to reverse layoffs, rehire lost staff: reports

Feb 24, 2025  0